jansen patient portal

What can I do on the Janssen carepath portal?

On the Janssen CarePath Portal, you can request benefits investigations; review the status of benefits investigation requests; enroll eligible, commercially-insured patients in the Janssen CarePath Savings Program; and view savings program transactions for your patients. Patient or Caregiver? Go to Patient Account

How can I get Started with my Janssen medications?

Janssen CarePath can help you get started--and stay on track--with your Janssen medications, as prescribed by your doctor. All information you submit in your Janssen CarePath Account will remain secure. Our Privacy Policy governs the use of the information you provide.

What is the Johnson&Johnson Patient Assistance Foundation?

Johnson & Johnson Patient Assistance Foundation, Inc. The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson.

See more

How long after Xarelto can you remove an epidural?from janssencarepath.com

An indwelling epidural or intrathecal catheter should not be removed before at least 2 half-lives have elapsed (ie, 18 hours in young patients aged 20 to 45 years and 26 hours in elderly patients aged 60 to 76 years), after the last administration of XARELTO ®.

What is rivaroxaban used for?from janssencarepath.com

Treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Reduction in the Risk of Recurrence of DVT and of PE:In patients with CrCl <30 mL/min, rivaroxaban exposure and pharmacodynamic effects are increased compared to patients with normal renal function. There are limited clinical data in patients with CrCl 15 to <30 mL/min; therefore, observe closely and promptly evaluate any signs or symptoms of blood loss in these patients. There are no clinical data in patients with CrCl <15 mL/min (including patients on dialysis); therefore, avoid the use of XARELTO®in these patients. Discontinue XARELTO®in patients who develop acute renal failure while on treatment.

What is Janssen committed to?from janssen.com

Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.

What is the name of the medicine that is used to treat a remicade?from janssencarepath.com

Use the medicines Kineret (anakinra), Orencia (abatacept) or Actemra (tocilizumab) or other medicines called biologics used to treat the same problems as REMICADE ® .

What is JJPAF in medicine?from janssen.com

JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.

How many patients did Johnson and Johnson help in 2019?from janssen.com

In 2019, the Janssen Pharmaceutical Companies of Johnson & Johnson helped approximately 1.3 million patients through the Janssen CarePath program. This includes approximately 540,000 commercially insured patients who reduced their out-of-pocket expenditures through the Janssen CarePath Savings Program.

How long after stopping stalara can you get BCG?from janssencarepath.com

You should not receive the BCG vaccine during the one year before receiving STELARA® or one year after you stop receiving STELARA®. have any new or changing lesions within psoriasis areas or on normal skin. are receiving or have received allergy shots, especially for serious allergic reactions. receive or have received phototherapy ...

What is Janssen committed to?

Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.

What is PPA in healthcare?

The Partnership for Prescription Assistance (PPA) helps qualifying U.S. patients without prescription drug coverage get the medicines they need for free or nearly free. PPA offers a single point of access to more than 475 public and private programs, including nearly 200 offered by pharmaceutical companies.

What is JJPAF in medicine?

JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.

What is JJPAF?

The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson. JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.

Welcome to Janssen CarePath

Janssen CarePath provides resources focused on access, affordability and treatment support to help your patients get started and stay on the Janssen medications you prescribe.

The email address you entered has not yet been verified

To resend the verification email, click the button below. If you still haven't received a verification email contact us at 877-CarePath (877-227-3728) Monday-Friday 8:00 AM to 8:00 PM ET

We could not find an account associated with that email

Click "Try Again" to go back and re-try entering your email, or register for a new account by clicking the "Register Now" button below.

What is the name of the medicine that is used to treat a remicade?from remicade.com

Use the medicines Kineret (anakinra), Orencia (abatacept) or Actemra (tocilizumab) or other medicines called biologics used to treat the same problems as REMICADE ® .

How long after birth can a baby get a remicde?from janssencarepath.com

Tell your baby’s doctor about your REMICADE ® use. If your baby receives a live vaccine within 6 months after birth, your baby may develop infections with serious complications that can lead to death. Recently received or are scheduled to receive a vaccine.

What type of lymphoma is not reported?from drugs.com

Frequency not reported: Hepatosplenic T-cell lymphoma (primarily in adolescents and young adults with Crohn's disease and ulcerative colitis ), Merkel cell carcinoma

What are the most common adverse reactions to Remicade?from janssencarepath.com

In clinical trials, the most common adverse reactions occurring in >10% of REMICADE ® -treated patients included infections (eg, upper respiratory, sinusitis, and pharyngitis), infusion-related reactions, headache, and abdominal pain.

What are the causes of infections that keep coming back?from janssencarepath.com

Infections that keep coming back, have diabetes or an immune system problem.

What are the symptoms of heart failure?from janssencarepath.com

Heart failure —new or worsening symptoms, such as shortness of breath, swelling of ankles or feet, or sudden weight gain.

How long after first dose of chemo can you get malignancies?from janssencarepath.com

The malignancies occurred after a median of 30 months after the first dose of therapy.

What is Janssen committed to?from janssen.com

Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.

What is PPA in healthcare?from janssen.com

The Partnership for Prescription Assistance (PPA) helps qualifying U.S. patients without prescription drug coverage get the medicines they need for free or nearly free. PPA offers a single point of access to more than 475 public and private programs, including nearly 200 offered by pharmaceutical companies.

What is JJPAF in medicine?from janssen.com

JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.

What is JJPAF?from janssen.com

The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a nonprofit organization that assists U.S. patients without adequate financial resources and prescription coverage in obtaining free products donated by the operating companies of Johnson & Johnson. JJPAF is an independent organization that reflects the long-standing commitment of the Johnson & Johnson operating companies to help patients access prescription medicines. Please visit the JJPAF website for more information regarding eligibility.